Cosmetic Peptide

Argireline

Acetyl hexapeptide-3 · Acetyl hexapeptide-8 · AH3

Argireline (Acetyl Hexapeptide-8) is a hyper-targeted, cosmetic synthetic hexapeptide globally recognized as the premier topical "Botox alternative." Extensively engineered to penetrate the epidermal barrier without needles, it is utilized in elite cosmeceutical formulations to explicitly target the superficial facial musculature. It works by forcibly interrupting the neural signaling that drives micro-contractions, profoundly flattening dynamic expression lines and crow’s feet.

Not FDA-approved - research chemical
Reviewed by CalcMyPeptide Editorial Team
Last updated: August 2026Evidence: Low1 peer-reviewed citation
Typical research dose
5-10% topical solution
Frequency
2× daily (topical)
Half-life
Topical application (variable)
Common vials
N/A (oral)
CAS
616204-22-9
Molecular weight
888.99 g/mol

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

  • Skin / cosmetic4/10

    Cosmetic in vitro / small topical studies. Not Botox. Not a reconstitution peptide.

Compound card

Class
Acetyl hexapeptide-8 (topical SNARE-targeting cosmetic)
Formula
C34H60N14O12S
Status
Not FDA-approved · research use

How it works

Argireline (Acetyl Hexapeptide-8) is a synthetic cosmetic peptide designed to mimic the N-terminal end of SNAP-25, a protein essential for the SNARE complex. The SNARE complex is required for neurons to release acetylcholine, the neurotransmitter that causes muscle contraction.

By mimicking SNAP-25, Argireline competitively binds to the SNARE complex, destabilizing it. This prevents the release of acetylcholine in the skin, mildly paralyzing superficial facial muscles. This mechanism - often called "Botox in a bottle" - smooths dynamic wrinkles (like crow's feet and forehead lines) without requiring injections.

Source: PMID: 21423551

Background & History

Argireline was developed by Lipotec (now part of Lubrizol) in Barcelona as the first cosmetic peptide to target neuromuscular junction signaling. Launched commercially in 2002, it became one of the most commercially successful cosmetic peptides, marketed as a "Botox in a jar." While its efficacy is significantly less than botulinum toxin, its non-invasive topical application and excellent safety profile have made it a staple in premium anti-aging skincare.

Research Use Cases

  • ✓Fine line reduction
  • ✓Expression wrinkle softening
  • ✓Preventive anti-aging skincare
  • ✓Botox alternative for needle-phobic patients

Dosing

PhaseDoseFrequencyNotes
Cosmetic Use5% - 10% solutionTopical, 1-2x dailyApplied directly to areas of dynamic wrinkles (forehead, around eyes).

Administration

Route / form
Topical serum
Timing
Morning and evening skincare routine.
Empty stomach?
No - Food timing is not critical.

Timeline

Week 2-4
Reduction in the depth and sheer volume of dynamic facial wrinkles.

Who it is for

Cosmetic Anti-Aging

Moderate

Specifically for dynamic wrinkles caused by repeated facial expressions.

Safety & Considerations

Topical cosmetic. Not a neuromuscular drug. Does not penetrate deeply enough to affect systemic neuromuscular junctions. Generally recognized as safe for skincare.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Limits of current evidence

  • SNAP-8 is a related but different sequence.

Verdict

Argireline is acetyl hexapeptide-8, a topical expression-line peptide. It is not botulinum toxin. Empty vial list: do not BAC-water this.

Interactions & Contraindications

Topical use only - no systemic drug interactions. Compatible with most cosmetic actives including retinoids, vitamin C, and hyaluronic acid.

Synergies & Common Stacks

SNAP-8 is the next-generation octapeptide extension of Argireline with claimed enhanced potency at the same SNARE complex target.

Argireline (muscle relaxation) + Matrixyl (collagen stimulation) provides a dual-action anti-aging approach addressing both dynamic and static wrinkles.

Argireline for surface wrinkle relaxation + GHK-Cu for deeper tissue remodeling and collagen architecture improvement.

Frequently Asked Questions

Is Argireline exactly like Botox?▼
They share a similar pathway (inhibiting the SNARE complex), but Botox permanently cleaves the complex via injection, causing profound paralysis. Argireline only destabilizes it temporarily and is applied topically, providing much milder, reversible relaxation of surface wrinkles.

References

  1. Blanes-Mira C et al. “"A synthetic hexapeptide (Argireline) with antiwrinkle activity".” International Journal of Cosmetic Science (2002). PMID: 18498523

Looking for a trusted source? See our recommended suppliers

Independently tested · COA-verified · Save 10% with our exclusive code

See suppliers →